Daniel Heng

Dr Daniel Heng

MD, MPH, FRCPC
Pronouns: he/him

Positions

Professor

Cumming School of Medicine, Department of Oncology

Member

Arnie Charbonneau Cancer Institute

Affiliations

Medical Oncologist

Arthur J.E. Child Comprehensive Cancer Centre

Contact information

Phone number

Office: 403.521.3166

Location

Office: CC112F

Preferred method of communication

Administrative Assistant

Charmaine McLean
Email: Charmaine.McLean@ahs.ca

Telephone: 403.521.3166

Background

Educational Background

MD University of Calgary,

MPH Harvard University,

Biography

Dr. Heng is the Division Head of Medical Oncology at the Tom Baker Cancer Center in Calgary, Alberta and a Clinical Professor of Medicine at the University of Calgary. He received his MD from the University of Calgary and trained at the BC Cancer Agency and Cleveland Clinic Taussig Cancer Institute. He has a Masters of Public Health from Harvard University and has a keen interest in outcomes, prognostic factors and clinical trials research in kidney, bladder, prostate and testicular cancers.  

Research

Areas of Research

Area of Focus
  • Outcomes and Genomics of Urologic Malignancies including Renal Cell Carcinoma
Summary of Research

Dr. Daniel Heng leads the International mRCC Database Consortium (IMDC) which comprises of over 14,000 patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapies from over 40 cancer centers worldwide. There are associated tissue specimens from corresponding patients in the IMDC biorepository. With this, we have been fortunate to inform clinical practice in terms of prognostic factors, clinical trial benchmarks, sequencing of therapy and cytoreductive nephrectomy in patients with mRCC. This has led to the creation of the IMDC prognostic criteria (a.k.a. Heng Criteria) which are used to prognosticate patients today and guide treatment selection between immune-oncology agents and tyrosine kinase inhibitors.

Awards

  • Meritorious Service Cross (M.S.C. post-nominals) (Awarded for work in Kidney Cancer Research), Governor General of Canada on behalf of Her Majesty Queen Elizabeth II. 2017
  • Top 40 under 40, Avenue Magazine. 2015
  • Alvin and Mona Libin Scholarship in Medicine , University of Calgary. 2004
  • University of Calgary Chancellor's Club Scholar (Full Scholarship), University of Calgary. 1996

Publications